EP358: How Health Insurance Plan Design Can Lead to Patients Sacrificing Needed Care, Their Mental Health, and (Sometimes) Buying Groceries, With Wayne Jenkins, MD
Relentless Health ValueMarch 10, 2022
358
33:5146.49 MB

EP358: How Health Insurance Plan Design Can Lead to Patients Sacrificing Needed Care, Their Mental Health, and (Sometimes) Buying Groceries, With Wayne Jenkins, MD

First of all, anybody who thinks that your average citizen in the United States today is unaware of the financial double jeopardy of going to a doctor, going to an emergency room, getting a procedure is sorely mistaken. Americans today are well aware of the financial risk that they are taking by seeking healthcare in this country.

To illustrate this point, let me read the first couple of sentences from a New York Times best-selling book review: “The illness narrative, ending in financial ruin and decreased quality of life, has become one of the classic 21st-century American stories. In her debut essay collection, Emily Maloney documents the … intersections of money, illness and medicine. For Maloney, the primary experience of receiving health care is not merely a bodily or spiritual event but always … a financial one. She understands … the relationship of money to being ill, … to managing an unfathomable amount of debt.” This is a New York Times best-selling book in the beginning of 2022. 

Add to this something I saw Pete Scruggs write on LinkedIn a while back, which I found actionable. He said:  

“Patients selling personal items or taking on credit card debt after medical procedures is a failure of creativity in providing healthcare. It is possible to build creative health plans that reduce costs for patients with expensive procedures by giving wise guidance at the time patients need it the most.

“It is not enough for insurance to provide access to a wide range of health providers but effectively leave the patient in debt … after the procedures are done. It is possible to buy healthcare so well in the local community that employers can reduce cost dramatically at the time most needed by those using health services.”

And lastly, let me quote from a recent article in JAMA by David Scheinker, PhD; Arnold Milstein, MD; and Kevin Schulman, MD, which says, “The financial consequences of an underperforming health insurance market (one that is not holding down … cost … ) diminishes the quality of life affordable to US employees and their families and the financial viability of employers not in the health care industry.” 

So, in this healthcare podcast, I am speaking with Wayne Jenkins, MD, who is chief medical officer over at Centivo. Before his move into value-based healthcare about 10 years ago, Dr. Jenkins started his career as a radiation oncologist. He has also served as the chief clinician at a bunch of large health systems.

I wanted to have Dr. Jenkins on the show to discuss a recent report which was published by Centivo that methodically dissects how financial toxicity is affecting patients. This includes how it affects choices that employees/patients/members are making both in terms of the care they decide they are willing to pay for or, more likely, the financial risks they’re willing to take. 

In short, the three key findings of the report are as follows:

  1. Workers face mounting healthcare affordability issues, and health plan cost sharing features such as high deductibles are an underlying cause.
    • Just a quick spoiler here: Do you know the percentage of employees who are forgoing buying groceries in order to afford medical expenses left on their shoulders by their high-deductible health plan or by their health plan with excessive premiums? Going hungry isn’t just for minimum wage workers.
  2. Medical expenses are a significant cause of mental health and well-being issues for both individuals and also families.
  3. The conventional wisdom that health plan members will never “trade off” certain offerings for greater savings is simply false.

The big takeaway here, though, is that the situation that we have in this country today is not a secret among your average regular American civilian. They do fully understand that by entering a healthcare setting, they are very well trading off, in their attempt to be healthy and going to the doctor in pursuit of that aim, they are trading off their financial well-being. And that financial toxicity actually has health implications. If you can’t afford groceries, for example, or your mental health suffers, we get ourselves rather rapidly into a downward spiral, as you may be able to see.

Other episodes dedicated to the impact of financial toxicity and possible solutions are in the show notes. I’m just gonna mention here quickly, we talked to Marty Makary, MD, about his book called The Price We Pay (EP242). There’s an interview with Marshall Allen (EP328) and then also a very interesting conversation with Mark Fendrick, MD (EP308).  

You can learn more at centivo.com.  

Wayne Jenkins, MD, is the chief medical officer at Centivo. He is an accomplished physician and executive with a proven track record of patient-centered, revenue-driven results. Over the course of his career, he has consistently transformed large, complex healthcare systems into market leaders that deliver quality and value in a dynamically changing environment.

Prior to Centivo, he was the chief clinical officer for population health at Vanderbilt University Medical Center, where he provided clinical oversight of value-based care delivery and completed the formation of Medicare accountable care organizations (ACOs). Before his time at Vanderbilt University Medical Center, he served as the senior vice president and chief strategy officer of Orlando Health, as well as president of Orlando Health Physician Partners. Previously, Wayne was the chief of radiation oncology and then subsequently the medical director for the Florida affiliate of M.D. Anderson Cancer Center, a subsidiary of Orlando Health, Inc.

Wayne holds a bachelor’s degree from the University of Tennessee, an MD from Vanderbilt University School of Medicine, and a master’s of health policy and administration from Johns Hopkins University. He is board certified in radiation oncology and was recognized in Best Doctors in America annually from 1994 to 2015. He has published 18 scientific articles and is often sought out to speak at state and national conferences.


05:23 How is financial toxicity in healthcare affecting patients?
07:02 How do we define a “normal” deductible in today’s healthcare?
08:14 What’s the point of having a deductible? What does a plan gain from a high deductible?
10:43 How does the cost of a patient’s deductible correlate with their use of their health insurance?
12:51 EP308 with Mark Fendrick, MD.
15:18 How is health insurance actually sometimes reducing patients’ health?
16:24 What is the defining characteristic of those who are more adversely affected by high deductibles?
17:04 Why should CFOs consider plans with lower deductibles for their employees?
18:26 “Are there other ways to approach this in a marketplace, to get more value for what you’re paying for so this problem can be addressed?”
21:56 How should employers contemplate health plans moving forward?
22:24 “Having the health plan choice gives more financial viability in addition to that open access.”
22:58 “In some sense, [that] can be a zero-sum game. Do you get it in the premium, or is it paid in the higher deductible?”
23:45 “I think there are value choices in the market that may help negate some of the problems that we were just discussing.”
25:33 “I think conventional wisdom may be left over from the ’90s.”
26:49 Why does building these narrow networks have to be a science?
28:38 Does a narrow network adversely affect mental health?
32:20 “Narrow and excellent is not a bad choice for people.”

You can learn more at centivo.com

digitalhealth,healthcare,healthcarecosts,healthfinancing,healthtech,centivo,

Recent Episodes

EP468: Very Common Assumptions That Aren’t Actually True About Member Engagement and the Healthcare Industry, With Matt McQuide
March 20, 2025
468
34:3931.72 MB

EP468: Very Common Assumptions That Aren’t Actually True About Member Engagement and the Healthcare Industry, With Matt McQuide

This conversation today with Matt McQuide is such a follow-on to the episode from last week where I encapsulated a major theme from the past five or six episodes. I know I’m on a roll. The thing is, if an employer doesn’t take the initiative and steer members or help them navigate through our curre...

EP467: Connecting Sky-High ER Spend to Primary Care Access—Following the Dollar Through Carriers and Hospitals, With Stacey Richter
March 13, 2025
467
23:0921.19 MB

EP467: Connecting Sky-High ER Spend to Primary Care Access—Following the Dollar Through Carriers and Hospitals, With Stacey Richter

Here’s my new idea for an episode. Welcome to it. I want to talk about a major theme running through the last few episodes of Relentless Health Value. And this theme is, heads up, going to continue through a few upcoming shows as well. For a full transcript of this episode, click here . If you enjo...

EP466: What Is Rising Faster, Insurance Premiums or Hospital Prices? With Vivian Ho, PhD
March 06, 2025
466
36:1233.13 MB

EP466: What Is Rising Faster, Insurance Premiums or Hospital Prices? With Vivian Ho, PhD

This episode has three chapters. Each one answers a key question, and, bottom line, it all adds up to action steps directly and indirectly for many, including plan sponsors probably, community leaders, and also hospital boards of directors. Here’s the three chapters in sum. For a full transcript of...

EP465: The Not Super Effective Contracting Industry Norm, Where Jumbo Plans and Others Wind Up Paying $10,000 for $50 Drugs, With Chris Crawford
February 27, 2025
465
34:1531.34 MB

EP465: The Not Super Effective Contracting Industry Norm, Where Jumbo Plans and Others Wind Up Paying $10,000 for $50 Drugs, With Chris Crawford

First of all, everybody listening here has probably heard of the lawsuit in which J&J—and talking about J&J as a large employer here now, not as a drug company—but J&J is (or maybe was, there’s action afoot) being sued by a plan member because, here’s the short version, allegedly, the J...

EP464: ER Visits Now 6% of Total Plan Spend. Is It Upcoding or What? With Al Lewis
February 20, 2025
494
31:4028.99 MB

EP464: ER Visits Now 6% of Total Plan Spend. Is It Upcoding or What? With Al Lewis

Today, I am speaking with the one, the only Al Lewis, and we’re gonna talk about how 6% of a lot of plan sponsors’ total spend is now going to ER/ED (emergency room/emergency department) visits. That’s a lot of spend. For a full transcript of this episode, click here . If you enjoy this podcast, be...

EP463: Medicare Advantage Policies—Which Will Stay and Which Will Go Now? With Betsy Seals
February 13, 2025
463
35:1132.2 MB

EP463: Medicare Advantage Policies—Which Will Stay and Which Will Go Now? With Betsy Seals

Every Gen X’er listening to this is gonna be singing that Clash  song in your head for the rest of the day. So, let’s turn our attention to Medicare Advantage policy. And on the show today, I grill the one and only Betsy Seals to find out which policies she thinks are going to stay and which a...

Encore! EP384: How Shareholders Impact Carrier Behavior, Exactly and Specifically, With Wendell Potter
February 06, 202535:0132.05 MB

Encore! EP384: How Shareholders Impact Carrier Behavior, Exactly and Specifically, With Wendell Potter

I am drowning in all things Q1 right now. So, this week we’re going with an encore. But this is a great show to go back and reflect upon, as it’s about carriers and how shareholders impact the actions of said carriers. For a full transcript of this episode, click here . If you enjoy this podcast, b...

Listen and Follow

Sponsored by Aventria Health Group
©2025 BD Bridges LLC. All Rights Reserved.